Metabolomics study finds biomarkers predicting autism in newborns

FHS
May 15, 2024
3:59 am

A study in Communications Biology utilized metabolomics in newborns to identify markers that might predict autism spectrum disorder (ASD), finding distinct metabolic profiles in children with ASD compared to typically developing children.

Eli Lilly’s obesity drug Zepbound improved liver scarring in mid-stage MASH study

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier

June 5, 2024

Meta Title: “Forma Therapeutics Inc Files Patent for USP30 Inhibitor Compounds

Share this article According to GlobalData’s company profile on Forma Therapeutics, Cancer treatment biomarkers was a key innovation area identified from patents. Forma Therapeutics‘s grant

April 1, 2024

Pecans may help prevent obesity and reduce inflammation, study shows

Daily consumption of pecans have been shown to prevent obesity and a host of related health issues like fatty liver disease and diabetes, according to

August 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.